Safety Assessment of Weekly Intravenous Infusions of SNS-595 for the Treatment of Solid Tumors
The purpose of this study is to determine whether SNS-595 given intravenously weekly for 3 weeks is safe.
Neoplasms
DRUG: SNS-595
Other objectives of this study include measuring pharmacokinetics (how long the drug can be measured in the blood) and determining the dose and dose schedule for the next phase of studies with SNS-595.